ProCE Banner Activity

FAQs Regarding the Management of Pruritus in PBC

Clinical Thought

At a recent symposium, 2 experts and a patient living with primary biliary cholangitis (PBC) addressed frequently asked questions about managing pruritus in PBC. A summary of the most compelling Q&As from the symposium is provided in this commentary.

Released: December 23, 2024

Expiration: December 22, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This educational activity is supported by an educational grant from GlaxoSmithKline.

GlaxoSmithKline

Faculty Disclosure

Primary Author

Stuart C. Gordon, MD

Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Stuart C. Gordon, MD: researcher: AbbVie, Arbutus, COUR Pharmaceuticals, CymaBay, GlaxoSmithKline, Ipsen, Mirum Pharmaceuticals; advisor: CymaBay, GlaxoSmithKline, Ipsen.

Marlyn J. Mayo, MD

Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas

Marlyn J. Mayo, MD: consultant/advisor/speaker: CymaBay, GlaxoSmithKline, Intercept, Intra-Sana, Ipsen; researcher: CymaBay, GlaxoSmithKline, Intercept, Ipsen, Mirum.

Pam Rivard, RN

Person Living With PBC

Pam Rivard, RN, has no relevant financial relationships to disclose.